Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Oerlikon (OERL.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2022-03-307.5512.906Buy
2022-05-106.7812.206Buy
2022-08-097.5411.906Buy
2022-10-036.3011.305Buy
2022-11-076.4910.205Buy
2023-01-096.429.405Buy
2023-02-065.946.603Neutral
2023-05-314.424.802Neutral
2023-08-044.214.352Neutral
2024-01-043.753.802Neutral
2024-02-274.274.102Neutral
2024-05-134.814.502Neutral
2024-08-084.844.902Neutral
2024-12-053.693.602Neutral
2025-03-244.123.92Neutral
2025-05-143.924.05Neutral
2025-06-103.85-No Rating

Disclosures

  • UBS AG is acting as financial advisor to OC Oerlikon Corporation AG on its announced sale of Barmag to Rieter Holding AG.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
  • UBS Fund Management (Switzerland) AG beneficially owns more than 3% of the total issued share capital of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.